About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...
New research has revealed the role of two membrane proteins in the spread of misfolded α-synuclein from neuron to neuron.
Much of the research into α-synuclein, the major component of Lewy bodies in Parkinson’s and other neurodegenerative diseases, focuses on its role in synaptic vesicles and membranes. But could other ...
Researchers at Yale University School of Medicine (YSM) have discovered two proteins on the surface of motor neurons in the ...
Alzheimer’s disease is a long, slow neurodegenerative calamity, and scientists are still hunting for blood biomarkers that reflect all its specific stages. At the Clinical Trials on Alzheimer’s ...
SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...
The so-called isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance. A research team headed by Professor Dr Erdem Gültekin Tamgüney ...
Researchers visualize alpha-synuclein pathology in living patients with a neurodegenerative disorder
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of alpha-synuclein in the brain. Now, scientists have developed a radioligand that facilitates the ...
Case Western Reserve researchers have found a unique biochemical route that plays a role in Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results